Category Archives: PathXL

New technology will accelerate cancer diagnostics and drug development

New technology will accelerate cancer diagnostics and drug development

TissueMark software automatically marks and detects potentially cancerous sections in tissue samples with unprecedented levels of speed and accuracy... Find Out More
‘Dolly the Sheep’ Business Mastermind Joins Digital Pathology Company

‘Dolly the Sheep’ Business Mastermind Joins Digital Pathology Company

PathXL welcomes one of UK’s leading medtech minds onto their Board One of the leading names in the UK’s... Find Out More

PathXL provide digital microscopy systems for Molecular Pathology Laboratory and Biobank.

BELFAST, NORTHERN IRELAND, 9 January 2013: Crescent Capital’s PathXL is proud to be involved with the Northern Ireland Biobank... Find Out More
PathXL investment clinches Deal of the Month

PathXL investment clinches Deal of the Month

BELFAST, NORTHERN IRELAND, 2 January 2013: The seven-figure sum investment in medical technology company, PathXL, a Crescent Capital portfolio company, has been named... Find Out More

Seven figure investment announced by Belfast software pioneer PathXL

Digital pathology company to expand cancer research & diagnosis support products  BELFAST, NORTHERN IRELAND, 13 December 2012:  PathXL, a... Find Out More
Frost & Sullivan Honours PathXL with Enabling Technology Award

Frost & Sullivan Honours PathXL with Enabling Technology Award

PathXL Recognised for its Pioneering Digital Pathology Solutions LONDON, April 19, 2012 /PRNewswire/ — Based on its recent analysis of web-based software... Find Out More